PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Radiation Oncology Journal10.3857/roj.2015.015712016344260-264Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinomaHun Jung Kim, Jeong Hoon Phak, Woo Chul Kimhttp://www.e-roj.org/journal/view.php?doi=10.3857/roj.2015.01571, http://www.e-roj.org/upload/pdf/roj-2015-01571.pdf, http://www.e-roj.org/upload/pdf/roj-2015-01571.pdf
Cancer Treatment Communications10.1016/j.ctrc.2016.01.0012016546-50Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy for low- and intermediate-risk prostate cancerJeong Hoon Phak, Hun Jung Kim, Woo Chul Kimhttps://api.elsevier.com/content/article/PII:S2213089616300019?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2213089616300019?httpAccept=text/plain
European Journal of Cancer10.1016/s0959-8049(17)30696-2201772S193-S194SHARP hypofractionated stereotactic radiotherapy is low and intermediate-risk prostate carcinoma patients – PSA outcomeM. Rucinska, K. Osowiecka, S. Nawrockihttps://api.elsevier.com/content/article/PII:S0959804917306962?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0959804917306962?httpAccept=text/plain
Radiotherapy and Oncology10.1016/s0167-8140(15)31425-02014111S90-S91EP-1307: Hypofractionated stereotactic body radiation therapy in low-risk prostate cancerH.J. Kim, W.C. Kimhttps://api.elsevier.com/content/article/PII:S0167814015314250?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0167814015314250?httpAccept=text/plain
Asia-Pacific Journal of Clinical Oncology10.1111/ajco.125662016124388-395Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancerSeok Ho Lee, Hun Jung Kim, Woo Chul Kimhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fajco.12566, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fajco.12566, http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12566/fullpdf
Radiation Oncology10.1186/s13014-016-0585-y2016111Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancerMekhail Anwar, Vivian Weinberg, Zachary Seymour, I. Joe Hsu, Mack Roach, Alex R. Gottschalkhttp://link.springer.com/content/pdf/10.1186/s13014-016-0585-y.pdf, http://link.springer.com/article/10.1186/s13014-016-0585-y/fulltext.html, http://link.springer.com/content/pdf/10.1186/s13014-016-0585-y, http://link.springer.com/content/pdf/10.1186/s13014-016-0585-y.pdf
Radiotherapy and Oncology10.1016/j.radonc.2021.02.0282021158184-190Ultra-hypofractionated radiotherapy for low- and intermediate risk prostate cancer: High-dose-rate brachytherapy vs stereotactic ablative radiotherapyYat Man Tsang, Hannah Tharmalingam, Katherine Belessiotis-Richards, Shreya Armstrong, Peter Ostler, Robert Hughes, Roberto Alonzi, Peter J Hoskinhttps://api.elsevier.com/content/article/PII:S0167814021060916?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0167814021060916?httpAccept=text/plain
Asia-Pacific Journal of Clinical Oncology10.1111/ajco.12472201613121-27Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost and whole pelvic radiotherapy for intermediate- and high-risk prostate cancerHun Jung Kim, Jeong Hoon Phak, Woo Chul Kimhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fajco.12472, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fajco.12472, http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12472/fullpdf
Seminars in Radiation Oncology10.1016/j.semradonc.2017.02.0062017273268-278Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate CancerAmar U. Kishan, Christopher R. Kinghttps://api.elsevier.com/content/article/PII:S105342961730022X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S105342961730022X?httpAccept=text/plain
Radiotherapy and Oncology10.1016/s0167-8140(15)41234-42015115S672-S673EP-1242: Stereotactic body radiotherapy boost after whole pelvis radiotherapy in intermediate or high risk prostate cancerH.J. Kim, W.C. Kimhttps://api.elsevier.com/content/article/PII:S0167814015412344?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0167814015412344?httpAccept=text/plain